1[1]Lee MS, Yost RA. Rapid identification of drug metabo- lites with tandem mass spectrometry[J]. Biomed Environ Mass Spectrom, 1988, 15(4): 193.
2[2]Pang S, Zheng N , Felix CA,et al.Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry[J]. J Mass Spectrom, 2001, 36(7): 771
3[3]Naylor S, Kajbaf M, Lamb JH,et al.An evaluation or tandem mass spectrometry in drug metabolism studies[J].Biol Mass Spectrom, 1993, 22(7):388.
4[4]Brady TC, Kind AJ, Hyde WH, et al. Isolation, purification and structural characterization of flunixin the urine of greyhound dogs[J].Drug Metab Dispos, 1998, 26(4):294.
5[5]Zhong L,Eisenhandler R, Yeh KC . Determination of famotidine in low- volume human plasma by normal- phase liquid chromatography/tandem mass spectrometry[J].J Mass Spectrom, 2001, 36(7): 736.
6[6]Gu M, Lim HK.An intelligent data acquisition system for simultaneous screening of microsomal stability and metabolite profiling by liquid chromatography/mass sp- ectrometry[J].J Mass Spectrom, 2001, 36(9): 1 053
7[7]Yeung B, Vouros P, Reddy GS. Characterization of vitamin D3 metabolites using continuous- flow fast atom bombardment tandem mass spectrometry and high- performance liquid chromatography[J].J Chromatogr, 1993, 645(1): 115
8[8]Gilbert JD, Olah TV, Morris MJ, et al. The use of stable isotope labeling and liquid chromatography tandem mass spectrometry technique to simultaneously determine the oral and ophthalmic bioavailability of timolol in drugs[J].J Chromatogr Sci, 1998, 36(4): 163.
9[9]Furuta T, Okamiya K, Shibasake H, et al.Pharmacokin- etics of stable isotopically labeled activities[J].Drug Metab Dispos, 1996, 24(1): 49.
10[10]Akira K. Studies on the steroselective internal acyl mi- gration of ketoprofen glucuronides using 13C labeling and nuclear magnetic resohance spectroscopy[J].Drug Metab Dispos, 1998, 26(5): 457
6de Lange E C, de Boer B A, Breimer D D. Microdialysis for pharmacokinetic analysis of drug transport to the brain[J]. Adv Drug Del Rev, 1999, 36(2/3):211-227.
7Gobburu J V S, Chen E P. Artificial neural networks as a novel approach to integrated pharmacokinetics-pharmacodynatic analysis[J]. J Pharma Sci, 1996, 85(5):505-510.
